Letermovir (Prevymis) Okayed for Stem Cell Transplant Infection Letermovir (Prevymis) Okayed for Stem Cell Transplant Infection
The drug prevents cytomegalovirus infections and disease in adults previously exposed to the common virus who have received an allogeneic hematopoietic stem cell transplant.FDA Approvals
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Alert Source Type: news
More News: Cancer & Oncology | Cytomegalovirus | Health | Hematology | Stem Cell Therapy | Stem Cells | Transplants